Navigation Links
Allegheny General Hospital Launches Study to Determine Best Practices for Treating Epilepsy in the Emergency Room
Date:8/12/2015

Allegheny General Hospital, part of the Allegheny Health Network, is one of 39 medical centers across the United States participating in a clinical trial to help determine better ways to treat patients with prolonged seizures in Emergency Departments.

Currently, there is not a standardized protocol for emergency treatment of Status Epilepticus (SE), a seizure or recurrent seizures lasting longer than five minutes without stopping or waking up. A person whose seizure doesn’t stop after receiving a full dose of medicine designed to stop seizures is considered to have Established Status Epilepticus (ESE).

The Established Status Epilepticus Treatment Trial (ESETT) will study three commonly used medicines given in the Emergency Department for ESE, phenoytoin, valproic acid and levetiracetam, to determine which of these is safest and most effective.

“Physicians use their best judgment to treat seizures in an emergency setting, but there currently is no substantial clinical evidence to show that one medication stands out above the rest,” said Andrea Synowiec, DO, principal investigator of the study at Allegheny General.

“The data that we collect in the ESETT Trial will enable physicians to determine best practices and create a standard protocol for emergency treatment of ESE that will yield the best possible outcomes for patients, no matter where they are treated.”

Prolonged seizures can happen to people of any age, affecting the ability to think and remember, function normally and live independently. In serious cases, SE may limit awareness or cause coma, permanent brain damage or death. There are approximately 120,000 to 180,000 episodes of SE each year in the United States.

The ESETT trial will involve any patient 2 years or older with an active recurrent or ongoing seizure lasting longer than five minutes which fails to respond to a full dose of medication that should stop it. Patients will randomly receive one of the three study medications and blood samples may be taken. If the seizure does not stop, physicians will give extra medication, which could be one of the three study drugs or a different medication.

Because a person having a seizure is unable to provide consent to participate in research and the requirement of timely treatment makes it impossible to get consent from the patient’s family, patients will be enrolled without consent. This Exception from Informed Consent is lifted once the patient wakes up or his or her legal representative is located and the study team can inform them about the trial and request permission to continue in the study.

The ESETT study is part of the Neurological Emergencies Treatment Trials and Pediatric Emergency Care & Applied Research Network, which are funded by the National Institutes of Health. In addition to Allegheny General Hospital, UPMC Presbyterian Hospital and Children’s Hospital of Pittsburgh will also enroll patients in the ESETT trial.
To learn more about the study, including the opportunity to decline participation, visit http://www.esett.org or call 412.359.5075.

About Allegheny General Hospital
Allegheny General Hospital’s Neuroscience Program has long been regarded as one of the nation’s leading referral centers for the treatment of brain injuries and complex neurological diseases, including epilepsy. The Comprehensive Epilepsy Program at AGH was established in 1987 and has become one of the largest such services in the tri-state area. Along with diagnostic expertise, the program offers advanced medical and surgical treatments for epilepsy. AGH is a member of the National Association of Epilepsy Centers and has earned the Association’s highest Level 4 designation.

Read the full story at http://www.prweb.com/releases/2015/08/prweb12901465.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program
2. Allegheny Health Network Research Confirms Value of Less-Invasive POEM Procedure For Wider Range of Esophageal Disorders
3. Allegheny Health Network's Susan Manzi, MD, Receives National Lupus Advocacy Award
4. Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech
5. Allegheny General Hospital Introduces New Treatment for Relapsing Multiple Sclerosis
6. Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue
7. Allegheny Health Network Transplant Team Participates in Nation’s Largest Multi-State Paired Kidney Exchange
8. Western Pennsylvania’s First Robotic-Assisted Hip and Knee Surgeries Performed at Allegheny Health Network’s West Penn Hospital
9. Nationally-Recognized Cleveland Clinic Foot and Ankle Surgeon, James J. Sferra, MD, to Lead Allegheny Health Network Program
10. Allegheny Health Network Physician Research Points to Possible New Paradigm in Ovarian Cancer Treatment
11. Allegheny General Hospital Performs Milestone Transcatheter Aortic Valve Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2018)... BRASELTON, Ga. (PRWEB) , ... August 10, 2018 ... ... Southeast, is known for providing innovative procedures to metro Atlanta. Drs. Brent Sharpe ... procedures at Northeast Georgia Medical Center in Braselton. , On June 27, the ...
(Date:8/9/2018)... ... August 09, 2018 , ... Lyme disease is one of the fastest growing ... estimated 329,000 – a 25-fold increase since surveillance began in 1982. According to a ... all 50 states and the District of Columbia. Yet, Lyme and other insect borne ...
(Date:8/9/2018)... ... 09, 2018 , ... RiverGlade Capital (“RiverGlade”), is pleased to ... have an exclusive relationship with the firm. As an Operating Partner, Mr. ... sourcing, and deal origination, evaluation and diligence. He brings a wealth of ...
(Date:8/7/2018)... RAPIDS, Mich. (PRWEB) , ... August 07, 2018 , ... ... has partnered with Blue Sky Vision. Michael Sussex, OD, founded the practice in Coldwater, ... Dr. Sussex practices with Matt Austin, OD, to offer comprehensive eye health services for ...
(Date:8/3/2018)... ... August 03, 2018 , ... Firstaid4sport have been successfully selling ... the Firstaid4sport business in the 1990's and his son in law, Michael Davison ... providers in the UK of sports medicine products, supplying professional and amateur sports ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... ... August 02, 2018 , ... Although there is a wealth of advice ... and based on a generalized “best practices” approach. But now doctors and their patients ... for optimal health. , Technology exists to help people find the right diet and ...
(Date:8/2/2018)... ... August 02, 2018 , ... Juan M. Montero, ... international leader of sustainable advocacy. Sharon Kleyne, host of the internationally syndicated radio ... & Your Health sponsored by Nature’s Tears® EyeMist® on VoiceAmerica and World Talk ...
(Date:8/2/2018)... VANCOUVER, Canada (PRWEB) , ... August 01, 2018 ... ... solutions, is excited to announce the launch of its healthcare ecosystem that will ... Coral Health will make its platform available to the public and commence its ...
Breaking Medicine Technology: